Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€3.83

€3.83

-2.890%
-0.114
-2.890%
-
 
13.09.24 / Frankfurt WKN: A0M65T / Name: Hansa Medical AB / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Hansa Medical AB Stock

We can see a decrease in the price for Hansa Medical AB. Compared to yesterday it has lost -€0.114 (-2.890%).
For the coming years our community has positive and negative things to say abot the Hansa Medical AB stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.

Pros and Cons of Hansa Medical AB in the next few years

Pros
?
M***** P*******
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

The financials of Hansa Medical AB, a company in the Biotechnology & Medical Research sector, present a complex picture that evokes both concern and caution. With significant operating losses and a challenging cash flow position, there are considerable risks associated with the company's financial health. However, the presence of notable assets and a robust cash position indicate that all is not lost. As the analysis unfolds, it will delve deeper into the facets of Hansa Medical's financial statements, exploring the various strengths and weaknesses they embody.

Pros of Hansa Medical AB's Financials:

Strong Cash Reserves: One of the most alluring aspects of Hansa Medical's financials is the substantial cash available. As of the most recent balance sheet, cash holdings amounted to approximately €732 million. This liquidity provides a crucial buffer for operational expenses, potential investments, and unforeseen challenges. A strong cash position can help fund R&D initiatives or absorb operational losses during development phases.